At Cetero, we value the collaborative research conducted at each of our sites with leading pharmaceutical, biotech and generic companies. This Scientific Exchange between industry thought leaders, provides an open forum for the healthcare industry to benefit for our collective expertise.
More than 25 years of experience in clinical research and development has taught us many things—most importantly that collaboration, information and education enable our industry to flourish and benefit the scientific community as a whole.
Please select the appropriate Scientific Exchange link for recent news from Cetero Research.
Presentations
Objective and Subjective Responses to Simulated Weather Changes in Non-Allergic Rhinitis (NAR) Patients Using a Novel Environmental Exposure Chamber (EEC) Model
Lee J.S., Wilson D, Patel D, Bernstein J.A., D’Angelo P and Salapatek A Presented at the 2009 American College of Allergy, Asthma and Immunology Annual Meeting
The Use of an Environmental Exposure Chamber (EEC) Model for Challenging Non-Allergic Rhinitis (NAR) Patients to Irritant Triggers
Lee, J.S., Wilson, D, Patel, D, Bernstein, J.A., D’Angelo, P and Salapatek, A Presented at the 2009 American College of Allergy, Asthma and Immunology Annual Meeting
Quality of Life Improved in Ragweed Allergic Patients Treated with Captisol-Enabled® Budesonide+Azelastine Nasal Solution (CDX-313) Compared to Placebo and Reference Treatment (As + RA) Using an Environmental Exposure Chamber-specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-QOL)
Salapatek, A, McCue, S, Zimmerer, R.O. and Pipkin, J.D. Presented at the 2009 American College of Allergy, Asthma and Immunology Annual Meeting
Clinical Requirements for Subsequent Entry Inhaled Corticosteroid Products
Murray P. Ducharme, PharmD, FCCP, FCP, Chief Science Officer Presented at the 2009 Canadian Society of Pharmaceutical Sciences (CSPS) Symposium
Biosimilars and Bioequivalence Programmes
Murray P. Ducharme, PharmD, FCCP, FCP, Chief Science Officer Presented at the 2009 SMI Generics, Supergenerics Conference
First-in-Human Study Designs: Proof-of-Concept with Safety in Mind Graham Wood, PhD, Senior Scientific Liaison, Clinical Pharmacology Presented at the 2008 Ricerca Biosciences "Taking the Biotech from IP to IND" Symposium
Project Managers Forum Session: Resource Your Clinical Project Joanne Emmett, Vice President, Clinical Operations - Toronto Presented at the 2008 ACRP Global Conference & Exhibition
Performing Bioequivalence Studies Using Innovative or Historically Common Approaches
Murray P. Ducharme, PharmD, FCCP, FCP, Chief Science Officer
Presented at the 2007 SMI Generics, Supergenerics and Patent Strategies Symposium
Biosimilarity vs. Bioequivalence: Therapeutic Equivalence of Proteins and Petides
Murray P. Ducharme, PharmD, FCCP, FCP, Chief Science Officer Presented at the 2007 Canadian Society of Pharmaceutical Sciences (CSPS) Symposium
Population PKPD Approaches for the Assessment of Bioequivalence
Murray P. Ducharme, PharmD, FCCP, FCP, Chief Science Officer Presented at the 2007 Annual AAPS Meeting
Scientific Symposium on Cardiac Safety: Practical Considerations for Design and Implementation of Successful TQT Trials
Jeffrey S. Litwin, MD, Lawrence Z. Satin, MD and Alan Copa, PharmD Presented in November 2007
Healthy Normal vs. Patient Volunteers & Sample Size Determination & Number Of Cohorts Jeffrey S. Litwin, MD
Executive Vice President and Chief Medical Officer
eResearchTechnology, Inc. Audio-only
Number and Timing of Readings & Choosing the Right Dose Lawrence Z. Satin, MD, FACC Chief Medical Officer Cardiocore Audio-only
The Clinical Operational Execution Approach of TQT Trials Alan Copa, PharmD President – Fargo & East Grand Forks Cetero Research Audio-only
Scientific Symposium on Dermatology: Cadaver Skin Permeation Testing: A Critical Step in Your Drug Development
Paul A. Lehman, MSc, Thomas J. Franz, MD, Annette Bunge, PhD and Gerald B. Kasting, PhD Presented in November 2007
The Cadaver Skin Permeation Assay:
A Valid Surrogate for BA/BE Assessment – Fundamentals of the Cadaver Skin Assay
Focusing on In-vitro/In-vivo Correlation Paul A. Lehman, MSc Director, Clinical and Pre-clinical Dermatology Cetero Research
Critique/Conclusion
Brief critique by Dr. Annette Bunge (CSM)
and Dr. Gerald B. Kasting (UC) Audio
Role of Cadaver Skin Permeation Assay in New and Generic Drug Development – The Critical Path Initiative and Using the
Assay in the Drug Development Process Thomas J. Franz, MD Executive Medical Director, Dermatology Cetero Research
Critique/Conclusion
Brief critique by Dr. Annette Bunge (CSM)
and Dr. Gerald B. Kasting (UC) Audio
